A bibliometric analysis of regenerative medicine. (PDF) (link opens in a new window)
Analyses the impact of regenerative medicine research internationally and in the United Kingdom. Aims to map the global landscape of regenerative medicine research using a bibliometric analysis of research publications and their citations as a proxy for impact. Also aims to compare the overall UK strength in the field with the rest of the world. Relates to the report on taking stock of regenerative medicine (URN 11/1056).
Internet only
| 11/1059 | 18-07-2011 |
A4
67 Pages
|
|
A bioscience success story. Case study: accelerated drug discovery. (PDF) (link opens in a new window)
Report on a LINK applied genomics grant for nextgen sciences ltd.
Internet only
| 05/2130 | 01-01-2005 |
A4
1 Pages
|
|
A bioscience success story. Case study: cleaner rivers. (PDF) (link opens in a new window)
Project summary of a LINK applied genomics programme.
Internet only
| 05/2128 | 01-01-2005 |
A4
1 Pages
|
|
A bioscience success story. Case study: cleaning up contaminated land on operational sites. (PDF) (link opens in a new window)
Report on a LINK applied genomics project.
Internet only
| 05/2127 | 01-01-2005 |
A5
1 Pages
|
|
A bioscience success story. Case study: combating MRSA. (PDF) (link opens in a new window)
Information on a LINK applied genomics project.
Internet only
| 05/2126 | 01-01-2005 |
A4
1 Pages
|
|
A bioscience success story. Case study: detecting the spread of cancer. (PDF) (link opens in a new window)
Report on a exceptional SMART award for applied imaging international ltd.
Internet only
| 05/2129 | 01-01-2005 |
A4
1 Pages
|
|
A bioscience success story. Case study: point of care genetic testing. (PDF) (link opens in a new window)
Report on a LINK analytical biotechnology programme.
Internet only
| 05/2131 | 01-01-2005 |
A4
1 Pages
|
|
A study into the prospects for marine biotechnology development in the United Kingdom. Volume 1: strategy. (PDF) (link opens in a new window)
Analysis by the Foresight marine panel of the UK marine biotechnology sector highlighting key areas for development that would allow the sector to mature and flourish.
Internet only
| 05/1932 | 05-01-2005 |
A4
86 Pages
|
|
A study into the prospects for marine biotechnology development in the United Kingdom. Volume 2: background and appendices. (PDF) (link opens in a new window)
Analysis by the Foresight marine panel of the UK marine biotechnology sector highlighting key areas for development that would allow the sector to mature and flourish.
Internet only
| 05/1933 | 05-01-2005 |
A4
241 Pages
|
|
Analysis of the UK capabilities in industrial biotechnology in relation to the rest of the world. (PDF) (link opens in a new window)
Sector assessment by the bioscience for business knowledge transfer network for the industrial biotechnology innovation and growth team (IB-IGT). Assesses current activity in the production of platform chemicals from renewable sources and horizon scan to forecast potential future developments in science and technology activity in biocatalysis. Contributes towards the report on maximising UK opportunities from industrial biotechnology in a low carbon economy (URN 09/745).
Internet only
| 09/937 | 14-05-2009 |
A4
35 Pages
|
|
Annual report: progress against the recommendations in ‘Review and refresh of bioscience 2015’. (PDF) (link opens in a new window)
Reports on progress made by the Government to deliver on its commitments on the issues faced by the medical biotechnology sector in raising finance and investment, and the emerging issues impacting on the competitiveness and future of the sector. See URN 09/517 for 'The review and refresh of bioscience 2015'. Also relates to 'Life sciences 2010: delivering the blueprint' (10/542).
Internet only
| 10/535 | 26-01-2010 |
A4
29 Pages
|
|
Assessment of current activity in the production of platform chemicals from renewable sources and horizon scan to forecast potential future developments in science and technology activity in biocatalysis. (PDF) (link opens in a new window)
Technology assessment prepared by bioscience for business knowledge transfer network. The study was conducted in October and December 2008 and delivered information to inform the work of the industrial biotechnology innovation and growth team (IB-IGT in considering where the UK can best add value in the global supply chain and where to make recommendations for future investment. Contributes towards the report on maximising UK opportunities from industrial biotechnology in a low carbon economy (URN 09/745).
Internet only
| 09/941 | 14-05-2009 |
A4
57 Pages
|
|
BERR bioscience and health technology database: scope and segmentation guidance notes. (PDF) (link opens in a new window)
A guide to support the data partners to the bioscience and health technology database project on how to select and categorise the segmentation of the activities of the entities/organisations for inclusion in the database.
Internet only
| 09/995 | 26-05-2009 |
A4
59 Pages
|
|
Bioscience beacon projects. (PDF) (link opens in a new window)
Information about the six Beacon Projects: leading-edge research in bioinformatics, bio-imaging and bio-nanotechnology with strong industrial thrust being supported by DTI.
Internet only
| 04/1136 | 30-06-2004 |
A4
14 Pages
|
|
Bioscience LINK programme outputs: summary. (PDF) (link opens in a new window)
Description of LINK applied genomics and LINK bioremediation. These schemes promoted pre-competitive collaboration between industry and the research base.
Internet only
| 06/1583 | 18-07-2006 |
A4
1 Pages
|
|
Biotechnology clusters. (PDF) (link opens in a new window)
Report of a team led by Lord Sainsbury, Minister for Science on the development of the biotechnology sector in the UK.
Internet only
| 99/1027 | 05-08-1999 |
A4
58 Pages
|
|
Biotechnology exploitation platform (BEP) challenge. (PDF) (link opens in a new window)
An overview of the impact of the biotechnology exploitation platform (BEP) challenge, a bioscience legacy scheme.
Internet only
| 06/1586 | 10-07-2006 |
A4
6 Pages
|
|
Biotechnology mentoring and incubator (BMI) challenge. (PDF) (link opens in a new window)
Description of how the BMI challenge helped stimulate the creation and growth of high quality biotech companies through business incubation and mentoring.
Internet only
| 06/1582 | 18-07-2006 |
A4
1 Pages
|
|
Bio-wise: industrial and environmental applications of biotechnology. (PDF) (link opens in a new window)
Description of a DTI legacy scheme that promoted the use of biotechnology in industry.
Internet only
| 06/1585 | 18-07-2006 |
A4
1 Pages
|
|
Comparative statistics for the UK, European and US biotechnology sectors, analysis year 2003. (PDF) (link opens in a new window)
Report by Critical I Ltd providing the DTI with a robust and defensible analysis of the UK biotechnology sector’s comparative standing against some of its key European competitors and the United States.
Internet only
| 05/843 | 28-02-2005 |
A4
68 Pages
|
|
Comparative statistics for the UK, European and US biotechnology sectors, analysis years 2001 and 2002. (PDF) (link opens in a new window)
Report by Critical I Ltd providing the DTI with a robust and defensible analysis of the UK biotechnology sector’s comparative standing against some of its key European competitors and the United States.
Internet only
| 04/1861 | 30-11-2004 |
A4
84 Pages
|
|
Comparative statistics for the UK, European and US biotechnology sectors: analysis years 2003 & 2004. (PDF) (link opens in a new window)
Report by Critical I Ltd. Provides a comparison of UK biotechnology sector's standing relative to USA and three of the key European competitors as at the end of 2004.
Internet only
| 06/450 | 24-07-2006 |
A4
24 Pages
|
|
DTI bioscience beacon project outlines. (PDF) (link opens in a new window)
Synopsis of six R&D projects in bioinformatics, bio-imaging and bio-nanotechnology to help UK capitalise on its bioscience research base.
Internet only
| 06/1581 | 18-07-2006 |
A4
2 Pages
|
|
Final report and recommendations from the industrial biotechnology innovation and growth team (IB IGT) technology and manufacturing working group (T&MWG). (PDF) (link opens in a new window)
Report form the Technology & manufacturing working group of the IB-IGT which sets out the context for its work and its key findings which were used in the development of the report on maximising UK opportunities from industrial biotechnology in a low carbon economy (URN 09/745).
Internet only
| 09/977 | 14-05-2009 |
A4
13 Pages
|
|
Final report of the finance working group of the industrial biotechnology innovation and growth team (IB-IGT). (PDF) (link opens in a new window)
Report with recommendations from the finance & investment working group of the IB-IGT which sets out the context for its work and its key findings which were used in the development of the report on maximising UK opportunities from industrial biotechnology in a low carbon economy (URN 09/745).
Internet only
| 09/978 | 14-05-2009 |
A4
16 Pages
|
|
Genome valley: the economic potential and strategic importance of biotechnology in the UK report. (PDF) (link opens in a new window)
Describes the UK's position in biotechnology, outlines some of the ways in which biotechnology is already benefiting diverse sectors of the UK economy. In addition, future scenarios and barriers to development are identified, along with key actions critical to continuing success. Also lists UK research centres and companies involved in biotechnology
Internet only
| 99/1174 | 08-12-1999 |
A4
70 Pages
|
|
Government action to strengthen the UK’s position as a leading location for life sciences: letter to healthcare and life sciences stakeholders. (PDF) (link opens in a new window)
Letter from Lord Howe, Parliamentary Under-Secretary of State for the Department of Health, and David Willetts, Minister for Universities and Science. Summarises how the Government is helping the healthcare and life sciences sector.
Internet only
| 11/823 | 29-03-2011 |
A4
5 Pages
|
|
Government response to review and refresh of bioscience 2015 report. (PDF) (link opens in a new window)
Provides the Government's response to the recommendations that were in the review and refresh to Bioscience 2015 (URN 09/517). Structured around the themes of finance, increasing the update of new therapeutics, and human capital.
Internet only
| 09/920 | 07-05-2009 |
A4
36 Pages
|
|
Government response to the industrial biotechnology innovation & growth team report to Government 'IB 2025: maximising UK opportunities from industrial biotechnology in a low carbon economy'. (PDF) (link opens in a new window)
Report from Government setting out its response to the recommendations made in the final report of the industrial biotechnology innovation and growth team (URN 09/745) which analysed future barriers and opportunities for the sector.
Internet only
| 09/993 | 22-06-2009 |
A4
32 Pages
|
|
IB 2025: maximising UK opportunities from industrial biotechnology in a low carbon economy. (PDF) (link opens in a new window)
A report to Government from the industrial biotechnology innovation and growth team (IB IGT). Analyses future barriers and opportunities for the sector and makes recommendations on how to take the industry forward.
Internet only
| 09/745 | 14-05-2009 |
A4
74 Pages
|
|
Industrial biotechnology in the chemicals and chemistry-using industries in the UK: follow-up survey to assess barriers to implementation and opportunities for growth. (PDF) (link opens in a new window)
A follow up survey, for the industrial biotechnology innovation and growth team, performed to provide more detailed information at a national level on the use of industrial biotechnology in the chemicals and chemistry-using sectors in the United Kingdom. Aims to assist industry and Government frame the conditions to develop competitive, industrial biotechnology based chemicals production throughout the UK economy, and contributes towards the report on maximising UK opportunities from industrial biotechnology in a low carbon economy (URN 09/745).
Internet only
| 09/940 | 14-05-2009 |
A4
24 Pages
|
|
Industrial biotechnology innovation and growth team: newsletter 1 - September 2008. (PDF) (link opens in a new window)
Newsletter setting out progress of the industrial biotechnology innovation and growth team (IB-IGT), an industry-led project facilitated by BERR to giving a collective view from the UK chemical and bioscience industries on the innovation and growth challenges in industrial biotechnology.
Internet only
| 08/P66a | 06-10-2008 |
A4
2 Pages
|
|
Industrial biotechnology innovation and growth team: newsletter 2 - April 2009. (PDF) (link opens in a new window)
Newsletter setting out progress of the industrial biotechnology innovation and growth team (IB-IGT), an industry-led project facilitated by BERR to giving a collective view from the UK chemical and bioscience industries on the innovation and growth challenges in industrial biotechnology.
Internet only
| 09/P66a | 15-04-2009 |
A4
2 Pages
|
|
Investing in UK health and life sciences. (PDF) (link opens in a new window)
Overview of how the Government will ensure that the UK is a world class centre for discovery, development, manufacture and adoption of medical innovations. Explains how the Government aims to join up life sciences in the UK, open up universities and business to more collaboration, to invest in the best British ideas at an early stage, to remove regulatory barriers, and open up the NHS to new innovations and new clinical trials. For further information on the UK life sciences sector, see the ‘Strategy for UK life sciences’ URN 11/1429.
Internet only
| 11/1428 | 05-12-2011 |
A4
20 Pages
|
|
Medical technology metrics. (PDF) (link opens in a new window)
Spreadsheet containing a set of statistical tables and charts that give a detailed picture of the nature and attributes of the UK based medical technology industry. See also introduction and commentary URN 08/1012.
Internet only
| 08/1088 | 10-07-2008 |
XLS
25 Pages
|
|
Medical technology metrics: introduction and commentary. (PDF) (link opens in a new window)
Background to and summary of a set of statistics (URN 08/1088) that give a detailed picture of the nature and attributes of the UK based medical technology industry.
Internet only
| 08/1012 | 08-07-2008 |
A4
8 Pages
|
|
Patents for genetic sequences: the competitiveness of current UK law and practice. (PDF) (link opens in a new window)
A study of patents for genetic sequences carried out by the Intellectual Property Institute (IPI) on behalf of the DTI. Includes CD-ROM.
Internet only
| 04/937 | 19-04-2004 |
A4
168 Pages
|
|
Public perceptions of industrial biotechnology. (PDF) (link opens in a new window)
A report of a joint BERR and Sciencewise project to assess the public perception of industrial biotechnology based on a series of citizens juries involving members of the public, scientists, non-government organisations and industry representatives. The research was qualitative and exploratory in nature, and sought to understand what excites and worries people about this emergent technology in a variety of its applications. This contributed towards the report by the industrial biotechnology innovation and growth team on maximising UK opportunities from industrial biotechnology in a low carbon economy (URN 09/745).
Internet only
| 09/950 | 14-05-2009 |
A4
51 Pages
|
|
Quantitative modelling of industrial biotechnology and renewable chemicals. (PDF) (link opens in a new window)
Economic analysis identifying and quantifying future market growth opportunities and challenges in industrial biotechnology. Focuses on quantifying how identified drivers and forces and the use of policy levers could affect the sector over the next 15 years and beyond under four different future scenarios. It contributes towards the report by the industrial biotechnology innovation and growth team on maximising UK opportunities from industrial biotechnology in a low carbon economy (URN 09/745).
Internet only
| 09/962 | 14-05-2009 |
A4
69 Pages
|
|
Regenerative medicine call for evidence. (PDF) (link opens in a new window)
Sought perspectives on the opportunities and needs of regenerative medicine, as well as barriers to progress, from which Government can identify policy gaps. Call for evidence closed on 11 March 2011.
Internet only
| 11/685 | 28-01-2011 |
A4
2 Pages
|
|
Regenerative medicine: the patent landscape in 2011. (PDF) (link opens in a new window)
Updates a patent analysis of regenerative medicine from 2006 analysis by the Intellectual Property Office for BIS. It is specifically based around the country of residence of patent applicants to give a better indication as to the location of any innovative activity. Covers the time period 1991 to the present. See also the report on taking stock of regenerative medicine (URN 11/1056).
Internet only
| 11/1087 | 18-07-2011 |
A4
31 Pages
|
|
Strategy for UK life sciences. (PDF) (link opens in a new window)
The Government's strategy for the UK life sciences industry. Focusing on the healthcare applications of biology. Explains how the UK will become the global hub for life sciences in the future, providing an unrivalled ecosystem that brings together business, researchers, clinicians and patients to translate discovery into clinical use for medical innovation within the NHS. The UK will provide an environment and infrastructure that supports pioneering researchers and clinicians to bring innovation to market earlier and more easily, making the UK the location of choice for investment. Life sciences will continue to be vibrant in the UK and will be a key contributor to sustained economic growth.
Internet only
| 11/1429 | 05-12-2011 |
A4
40 Pages
|
|
Strength and opportunity 2011: the landscape of the medical technology, medical biotechnology, industrial biotechnology and pharmaceutical sectors in the UK. Annual update - December 2011. (PDF) (link opens in a new window)
Third annual report analysing the updated 2011 dataset from the bioscience and health technology database. Relates to companies that are active in the UK in three of the life sciences sectors: medical technology, medical biotechnology and industrial biotechnology. Enables comparisons against last year’s information to see how these sectors are changing. Also features the pharmaceutical industry for the first time.
Internet only
| 11/P90 | 05-12-2011 |
A4
84 Pages
|
|
Strength and opportunity: the landscape of the medical technology, medical biotechnology and industrial biotechnology enterprises in the UK. December 2009. (PDF) (link opens in a new window)
First annual report analysing information from the bioscience and health technology database, which relates to companies that are active in the UK in three of the life sciences sectors.
Internet only
| 09/P90 | 10-12-2009 |
A4
48 Pages
|
|
Strength and opportunity: the landscape of the medical technology, medical biotechnology and industrial biotechnology sectors in the UK. Annual update - December 2010. (PDF) (link opens in a new window)
Second annual report analysing information from the bioscience and health technology database, which relates to companies that are active in the UK in three of the life sciences sectors: medical technology, medical biotechnology and industrial biotechnology. See also next annual report 11/P90.
Internet only
| 10/P90 | 10-12-2010 |
A4
63 Pages
|
|
Study into the potential energy and greenhouse gas savings of renewable chemicals and biocatalysts. (PDF) (link opens in a new window)
Report from North Energy for BERR that aims to develop and review the existing evidence base of potential energy savings possible by using renewable chemicals and biocatalysts. This contributed towards the report by the industrial biotechnology innovation and growth team on maximising UK opportunities from industrial biotechnology in a low carbon economy (URN 09/745).
Internet only
| 09/938 | 14-05-2009 |
A4
119 Pages
|
|
Survey to assess the use and awareness of industrial biotechnology in the chemicals and chemistry-using industries in the UK: survey results, analysis and recommendations. (PDF) (link opens in a new window)
Report of a survey undertaken for the industrial biotechnology innovation and growth team. Aims to provide an evidence base for the use of industry biotechnology in the chemicals and chemistry-using sectors in the United Kingdom, to assist industry and Government frame the conditions to develop competitive, industrial biotechnology based chemicals production throughout the UK economy. Includes survey results and recommendations. Contributes towards the report on maximising UK opportunities from industrial biotechnology in a low carbon economy (URN 09/745).
Internet only
| 09/939 | 14-05-2009 |
A4
21 Pages
|
|
Systems biology research for industry: DTI bioscience beacon projects: achievements and opportunities for industry engagement. (PDF) (link opens in a new window)
Report on the progress, achievements, results and lessons of the DTI bioscience Beacon projects to mid-2006, highlighting further opportunities for industry engagement.
Internet only
| 06/2052 | 30-11-2006 |
A4
48 Pages
|
|
Taking stock of regenerative medicine in the United Kingdom. (PDF) (link opens in a new window)
Assesses the state of the regenerative medicine field internationally and analyses the UK’s strengths, weaknesses and areas of opportunity. Identifies key barriers to the therapeutic and commercial use of regenerative medicines and sets out how Government will work to overcome them. Aims to provide a strong evidence base for the Government to coordinate funding decisions, and to lay the ground-work for an agreed strategy for regenerative medicine. See also reports on bibliometric analysis (URN 11/1059) and the patent landscape (11/1087).
Internet only
| 11/1056 | 18-07-2011 |
A4
58 Pages
|
|
The advisory and regulatory framework for biotechnology: report from the Government's review. (PDF) (link opens in a new window)
Report setting out changes in the advisory and regulatory framework for biotechnology in the light of the Government's review.
Internet only
| 99/863 | 20-05-1999 |
A4
43 Pages
|
|
The evaluation of DTI support for biotechnology. Annex A: UK performance in biotechnology-related innovation - an analysis of patent data. (PDF) (link opens in a new window)
Report prepared for the evaluation of DTI support for biotechnology. Contains a review of patenting activity of UK companies in the US patenting system. See also the main report URN 08/976 and annex B, 08/978.
Internet only
| 08/977 | 12-06-2008 |
A4
37 Pages
|
|
The evaluation of DTI support for biotechnology. Annex B: UK performance in science related to biotechnology - an analysis of publications data. (PDF) (link opens in a new window)
Report prepared for the evaluation of DTI support for biotechnology. Contains bibliometrics survey of publications and citations arising from UK research. See also main report URN 08/976 and annex A, 08/977.
Internet only
| 08/978 | 12-06-2008 |
A4
40 Pages
|
|
The evaluation of DTI support for biotechnology. Main report. (PDF) (link opens in a new window)
Assesses the appropriateness, strategic positioning, impacts and costs of the suite of support programmes designed to pull through technology from a strong science base into a UK industry characterised principally by small and medium sized enterprises, with the exception of the pharmaceutical sector. See also annexes URN 08/977 and 08/978.
Internet only
| 08/976 | 12-06-2008 |
A4
143 Pages
|
|
The Government response to Bioscience 2015, the report by the bioscience innovation and growth team. (PDF) (link opens in a new window)
Government response to Bioscience Innovation and Growth Team (BIGT) report published in November 2003, and strategy in response to the report. See also updated report URN 09/517.
Internet only
| 04/2334 | 01-01-2004 |
A4
25 Pages
|
|
The policy measures working group final report. (PDF) (link opens in a new window)
Report from the policy measures working group of the industrial biotechnology innovation and growth team (IB-IGT) which sets out the context for its work and its key findings which were used in the development of the report on maximising UK opportunities from industrial biotechnology in a low carbon economy (URN 09/745). Looks at how Government and industry can create an encouraging and enabling political and economic framework to catalyse the growth of the market for industrial biotechnology (IB) produced products, IB process solutions to societal needs, and IB technologies.
Internet only
| 09/976 | 14-05-2009 |
A4
12 Pages
|
|
The review and refresh of bioscience 2015. (PDF) (link opens in a new window)
Report from the bioscience innovation and growth team (BIGT). Reviews the previous BIGT report (URN 03/1321) and looks at future opportunities and barriers for the sector. See URN 10/535 for a progress report.
Internet only
| 09/517 | 22-01-2009 |
A4
72 Pages
|
|
UK Texas bioscience collaboration initiative. (PDF) (link opens in a new window)
Description of the outcomes of a programme that brought together researchers from the UK and the USA to facilitate knowledge transfer.
Internet only
| 06/1584 | 18-07-2006 |
A4
1 Pages
|
|
